Photo Credit: Diego M. Radzinschi/ALM
The volume of securities fraud suits against life sciences companies set a nationwide record in 2017, and New Jersey is emerging as a leading venue for such cases, according to a report issued by Dechert.
February 14, 2018 at 04:31 PM
1 minute read
The original version of this story was published on New Jersey Law Journal
The volume of securities fraud suits against life sciences companies set a nationwide record in 2017, and New Jersey is emerging as a leading venue for such cases, according to a report issued by Dechert.
Nationwide, plaintiffs filed 88 class action securities lawsuits against life sciences companies in 2017, an increase of more than 30 percent from the 67 suits filed in the previous year, and an increase of more than 225 percent from five years prior.
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
